Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Revenue

Zhejiang Medicine had revenue of 2.20B CNY in the quarter ending June 30, 2026, with 6.18% growth. This brings the company's revenue in the last twelve months to 8.94B, down -3.75% year-over-year. In the year 2025, Zhejiang Medicine had annual revenue of 8.88B, down -5.28%. That makes Zhejiang Medicine the 6,399th largest company in the world by revenue and 882nd in China.

• Revenue (ttm): 8.94B
• Revenue Growth: -3.75%
• P/S Ratio: 1.28
• Revenue / Employee: 1.65M
• Employees: 5,417
• Market Cap: 11.49B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.88B	-494.61M	-5.28%
Dec 31, 2024	9.38B	1.58B	20.29%
Dec 31, 2023	7.79B	-321.66M	-3.96%
Dec 31, 2022	8.12B	-1.01B	-11.10%
Dec 31, 2021	9.13B	1.80B	24.60%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error